The Defense Health Agency's goal for the Omnibus initiative is to transition findings and innovations from the R&D phase into medical practice to better delivery combat casualty care for patients suffering an injury or illness.
The University of Pittsburgh is one of two academic institutions in the nation to be awarded this 5-year Indefinite Delivery Indefinite Quantity (IDIQ) contract with a 5-year renewal with a total potential award (for the whole program) of up to $10 billion!
There are 4 Market Segments: Research and Development, Research and Development, Regulatory Processes and Translational Sciences Support and Services. University of Pittsburgh is a prime offeror for Research and Development and Translational Sciences Support and Services.
Our capabilities include:
1. Medical Simulation Technologies
2. Infectious Disease
3. Military Health, Performance & Recovery
4. Joint Battlefield Healthcare
5. Radiation Health Effects
6. Clinical & Rehabilitative Medicine
7. Chemical & Biological Readiness
8. Clinical Investigations, Graduate Health Science Education and Military Health Systems Research
9. Genomics & Omics
10. Emerging Science & Technology